Submucosal lift solution

País: Australia

Idioma: inglés

Fuente: Department of Health (Therapeutic Goods Administration)

Disponible desde:

Endomed Pty Ltd

clase:

Class IIa

Fabricado por:

GI Supply 5069 Ritter Road Suite 104, Mechanicsburg, Pennsylvania, 17055 United States Of America

Área terapéutica:

62217 - Submucosal lift solution

indicaciones terapéuticas:

Submucosal Lifting Agent is indicated for use in gastrointestinal endoscopic procedures for submucosal lift of polyps, adenomas, early stage cancers. or other gastrointestinal lesions prior to excision with a snare or other appropriate endoscopic device.

Estado de Autorización:

A

Fecha de autorización:

2022-01-10